Boston Scientific has long been committed to supporting the advancement of women in the workplace. Our focus on inclusion is rooted in our values and in our mission to transform lives.
International advocacy organization Global Citizen is proud to announce the appointment of six new members to its Global Board of Directors, along with three new additions to its Europe Board of Directors.
What is the role of multi-stakeholder partnerships in addressing the Sustainable Development Goals? Top experts from the field of corporate sustainability get beneath the surface of this issue, in the final two installments of SDGs: The Rising Tide.
After achieving its $8 billion renewable energy goal three years early, Fifth Third expanded its aim in 2022 and announced a 10-year, $100 billion environmental and social finance target through 2030.
Minderoo Foundation and Illumina, Inc. (NASDAQ: ILMN), today announced a 40 million Australian dollar (US $27.8 million) partnership that will leverage the power of genomics to accelerate scientific understanding of marine systems and help marine conservationists make informed decisions.
Kohler Co., a global leader in the innovation and manufacture of plumbing products; tile, cabinetry and lighting; and engines, generators and clean energy solutions, joins this year’s World Water Week conference as a panel
EcoVadis, the leading provider of globally trusted business sustainability ratings, today released its Carbon Maturity Report exploring the state of climate action in the EcoVadis Network.
In April of 2022, NortonLifeLock launched an innovative initiative, called the Sustainable Home Improvement Program. The incentive program reimburses employees for making sustainability improvements in their own homes.
Join the conversation with Lotti Hawkins, Executive Search - Sustainable Investing, ESG & Impact for Private Markets at Farrell Associates, as she and host Mandi McReynolds discuss building ESG talent, focusing on ESG strategy and transferable skills, and the rise of ESG in the C-suite.
Quest has expanded from our original primary focus on heart disease to a multi-pronged proactive approach that focuses on critical diagnostic insights across the cardiometabolic continuum.